Next 10 |
Canopy Growth Announces Financing to Further Strengthen Balance Sheet Including Approximately US$50 Million of New Gross Proceeds Canada NewsWire C$27.5 Millon of Debt Extended from 2025 to 2029 Providing Additional Balance Sheet Flexibility SMITHS FALLS, ON ...
A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) rose 2.3% to $12.22 on volume of 208,602,591 shares CytomX Therapeutics Inc. (CTMX) rose 214.7% to $5.13 on volume of 203,288,355 shares Akanda Corp. (AKAN) rose 25.4% to $0.1166 on volume of 179,349,234 shares ...
2024-05-01 15:13:54 ET Easy come, easy go. Yesterday, shares of cannabis companies like Canopy Growth (NASDAQ: CGC) , Tilray Brands (NASDAQ: TLRY) , and Cronos Group (NASDAQ: CRON) all soared on news that the U.S. Drug Enforcement Administration (DEA) has agreed to r...
2024-05-01 12:13:14 ET More on cannabis stocks Canopy Growth Stock: Expect A Crash After The High OMB review of cannabis rescheduling could put measure at risk MSOS: Best Play On U.S. Cannabis Regulations Aurora Cannabis: Improved Financials, Limite...
2024-05-01 10:00:09 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 19 out...
2024-05-01 09:00:05 ET Summary Shares of cannabis companies soared after news that the US DEA is considering reclassifying marijuana as a Schedule III drug. Canopy Growth Corporation saw the biggest increase, with CGC stock closing up 78.9%. However, Canopy Growth faces financ...
2024-05-01 08:51:46 ET The White House Office of Management and Budget's review of the DEA's likely reclassification of marijuana from a Class I to a Class III controlled substance could scuttle the reform, according to one assessment.... Read the full article on Seeking Alpha ...
2024-05-01 02:47:58 ET Summary SNDL Inc. rallied 22% as the DEA recommends rescheduling cannabis from Schedule I to Schedule III. The rally may lead to new valuations and price targets for cannabis companies. The rescheduling is a positive step, but further legislation and fed...
A look at the top 10 most actives in the United States Tilray Brands Inc. (TLRY) rose 39.5% to $2.47 on volume of 149,005,559 shares Tesla Inc. (TSLA) fell 5.6% to $183.28 on volume of 125,934,900 shares PROSHARES TRUST (SQQQ) rose 5.7% to $11.95 on volume of 124,394,426 shares Jaguar H...
2024-04-30 16:25:18 ET Summary The U.S. Drug Enforcement Administration (DEA) is moving marijuana from Schedule I to Schedule III under the Controlled Substances Act, and pending approval from the White House Office of Management and Budget. Rescheduling cannabis would allow U.S. ...
News, Short Squeeze, Breakout and More Instantly...
Canopy Growth Corporation Company Name:
CGC Stock Symbol:
NYSE Market:
Canopy Growth Corporation Website:
Canopy Growth Corporation (TSX:WEED) (NASDAQ: CGC) has entered into an exchange and subscription agreement with a single institutional investor und...
Canopy Growth Announces Financing to Further Strengthen Balance Sheet Including Approximately US$50 Million of New Gross Proceeds Canada NewsWire C$27.5 Millon of Debt Extended from 2025 to 2029 Providing Additional Balance Sheet Flexibility SMITHS FALLS, ON ...
Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already injecte...